Address
Rauhalinnantie 31
Kaarina
South-West Finland
20780, Finland
Contact
Tony Wahlroos+358400953873
tony.wahlroos@labmaster.fi
Website
Download PDF
POC tests differentiate bacterial and viral RTIs
CRP and MxA point-of-care testing allows for quick and accurate differentiation between viral and bacterial respiratory tract infections (RTIs). The tests are based on a small fingertip blood sample and produce a quantitative result within minutes.
Labmaster LUCIA™ tests are based on a small fingertip whole blood sample. The proprietary cathodic electrochemiluminescence technology guarantees accuracy of measurement. Its cost-effectiveness is achieved by replacing expensive optics with low-priced sophisticated electronics. A true quantitative result is ready within minutes. POC testing reduces the need for laboratory testing, expedites diagnostic decision-making and monitoring of treatment.
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Marketed product
- Research
- Development
- Validation
- Market entry
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Sell
- Outsource
- Joint Venture
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- RTI
- UTI
- STI
- BSI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Veterinary point-of-care diagnostics
Labmaster Ltd, in Finland, develops innovative diagnostics tools for clinical and research use. The Labmaster LUCIA™ Analyzer is a point of-care immunoassay platform based on patented cathodic electrochemiluminescence (LM-CECL) technology. It enables fast, accurate and affordable human and veterinary diagnostics of biomarkers in blood samples.
Veterinary point-of-care diagnostics
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!